Implantable sensors for heart failure

Circulation: Arrhythmia and Electrophysiology

Volumn 3, Issue 6, 2010, Pages 657-667

  Merchant, Faisal M ^a   Dec, G William ^b   Singh, Jagmeet P ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Congestive; Contractile function; Diagnostic testing; Heart failure; Other; Pacemaker; Treatment

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CASPASE; ELECTROLYTE; GLUCOSE; INTERLEUKIN 6; TROPONIN; TUMOR NECROSIS FACTOR ALPHA;

ACCELEROMETER; ACUTE DECOMPENSATED HEART FAILURE; APOPTOSIS; ARTICLE; CARBON DIOXIDE TENSION; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; GLYCOLYSIS; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART OUTPUT; HEART RATE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; IMPLANT; LUNG ARTERY PRESSURE; MICROTUBULE; OXYGEN SATURATION; OXYGEN TENSION; PH; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CARDIOVASCULAR SYSTEM EXAMINATION; DISEASE COURSE; EARLY DIAGNOSIS; EQUIPMENT DESIGN; INSTRUMENTATION; MONITORING; PATHOPHYSIOLOGY; PREVALENCE; REPRODUCIBILITY; REVIEW; SURVIVAL RATE; UNITED STATES;

DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; EARLY DIAGNOSIS; EQUIPMENT DESIGN; HEART FAILURE; HEART RATE; HUMANS; MONITORING, PHYSIOLOGIC; PREVALENCE; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; UNITED STATES;

EID: 79952117826     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.110.959502     Document Type: Article

References (60)

1. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007; 153:1021-1028. (Pubitemid 46809844)
2. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99 -104. (Pubitemid 27027080)
3. Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005;96:11G-17G.
4. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261: 884-888. (Pubitemid 19046417)
5. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007;116:1549 -1554. (Pubitemid 47511418)
6. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A metaanalysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009;54:1683-1694.
7. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring: the Home CARE pilot study. Clin Res Cardiol. 2006;95(Suppl 3):III29 -III35.
8. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107: 565-570. (Pubitemid 36176805)
9. Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kreiner G, Gossinger H, Schmidinger H, Pacher R, Weber H. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Electrophysiol. 1992;15:2215-2220.
10. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A, Rhodes MM. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110: 2389-2394. (Pubitemid 39407344)
11. Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005;46:1875-1882. (Pubitemid 41579811)
12. Braunschweig F, Mortensen PT, Gras D, Reiser W, Lawo T, Mansour H, Sogaard P, Stegemann B, Bruns HJ, Linde C. Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. Am J Cardiol. 2005;95: 1104-1107. (Pubitemid 40544321)
13. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation. 2003;108:266 -269. (Pubitemid 36899014)
14. Gilliam FR III, Singh JP, Mullin CM, McGuire M, Chase KJ. Prognostic value of heart rate variability footprint and standard deviation of average 5-minute intrinsic R-R intervals for mortality in cardiac resynchronization therapy patients. J Electrocardiol. 2007;40:336 -342. (Pubitemid 46961995)
15. Singh JP, Rosenthal LS, Hranitzky PM, Berg KC, Mullin CM, Thackeray L, Kaplan A. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace. 2009;11: 1647-1653.
16. Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, Nagueh SF. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation. 2004;109:2432-2439. (Pubitemid 38679564)
17. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol. 2009;55:53- 60.
18. Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol. 2010;55:645- 653.
19. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP. BNPguided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA. 2009;301:383-392.
20. Lewin J, Ledwidge M, O'Loughlin C, McNally C, McDonald K. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail. 2005;7:953-957. (Pubitemid 41443587)
21. Magalski A, Adamson P, Gadler F, Boehm M, Steinhaus D, Reynolds D, Vlach K, Linde C, Cremers B, Sparks B, Bennett T. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail. 2002;8:63-70. (Pubitemid 34521414)
22. Adamson PB, Kjellstrom B, Braunschweig F, Magalski A, Linde C, Kolodiezj A, Cremers B, Bennett T. Ambulatory hemodynamic monitoring from an implanted device: components of continuous 24-hour pressures that correlate to supine resting conditions and acute right heart catheterization. Congest Heart Fail. 2006;12:14 -19.
23. Reynolds DW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol. 1995;25:1176 -1182.
24. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T. Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:565-571. (Pubitemid 36223320)
25. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51:1073-1079. (Pubitemid 351374766)
26. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118: 1433-1441.
27. Plicchi G, Marcelli E, Parlapiano M, Bombardini T. PEA I and PEA II based implantable haemodynamic monitor: pre clinical studies in sheep. Europace. 2002;4:49 -54. (Pubitemid 36124394)
28. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT. Physiciandirected patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121:1086 -1095.
29. Abraham WT, Adamson P. Primary results of the CardioMEMS heart sensor allows monitoring of pressure to improve outcomes in NYHA class III heart failure patients (CHAMPION) trial ESC Heart Failure Congress 2010. Berlin, Germany, 2010.
30. Braunschweig F. Therapeutic and diagnostic role of electrical devices in acute heart failure. Heart Fail Rev. 2007;12:157-166. (Pubitemid 46923547)
31. Packer M, Abraham WT, Mehra MR, Yancy CW, Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM, Pina IL, Greenberg BH, Young JB, Fishbein DP, Hauptman PJ, Bourge RC, Strobeck JE, Murali S, Schocken D, Teerlink JR, Levy WC, Trupp RJ, Silver MA. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006;47:2245-2252. (Pubitemid 43795052)
32. Luthje L, Drescher T, Zenker D, Vollmann D. Detection of heart failure decompensation using intrathoracic impedance monitoring by a triplechamber implantable defibrillator. Heart Rhythm. 2005;2:997-999. (Pubitemid 41372291)
33. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112:841- 848. (Pubitemid 41170070)
34. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, Perego GB, Varbaro A, Denaro A, Valsecchi S, Vergara G. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol. 2009;32:363-370.
35. Vollmann D, Nagele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MR, Lamp B. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007;28: 1835-1840. (Pubitemid 47236638)
36. Khoury DS, Naware M, Siou J, Blomqvist A, Mathuria NS, Wang J, Shih HT, Nagueh SF, Panescu D. Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. J Am Coll Cardiol. 2009;53:1075-1081.
37. Stahl C, Beierlein W, Walker T, Straub A, Nagy Z, Knubben K, Greiner TO, Lippert M, Czygan G, Paule S, Schweika O, Kuhlkamp V. Intracardiac impedance monitors hemodynamic deterioration in a chronic heart failure pig model. J Cardiovasc Electrophysiol. 2007;18:985-990. (Pubitemid 47339042)
38. Stahl C, Walker T, Straub A, Kettering K, Knubben K, Greiner TO, Paule S, Lippert M, Czygan G, Schweika O, Kuhlkamp V. Assessing acute ventricular volume changes by intracardiac impedance in a chronic heart failure animal model. Pacing Clin Electrophysiol. 2009;32:1395-1401.
39. Maines M, Landolina M, Lunati M, Lonardi G, Pappone A, Proclemer A, Zanotto G, Santini M, Varbaro A, Vimercati M, Valsecchi S. Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol. 2010;33:64 -73.
40. Bocchiardo M, Meyer ZU, Vilsendorf D, Militello C, Lippert M, Czygan G, Gaita F, Schauerte P, Stellbrink C. Intracardiac impedance monitors stroke volume in resynchronization therapy patients. Europace. 2010;12: 702-707.
41. Bocchiardo M, Militello C, Azzaro G, Miceli S, Lercari F, Lippert M, Czygan G, Gaita F. Intracardiac impedance optimizes AV- and VV-delay in heart failure patients. Heart Rhythm. 2007;4:S397.
42. Hamilton LH, Beard JD, Kory RC. Impedance measurement of tidal volume and ventilation. J Appl Physiol. 1965;20:565-568.
43. Cole CR, Jensen DN, Cho Y, Portzline G, Candinas R, Duru F, Adler S, Nelson L, Condie C, Wilkoff BL. Correlation of impedance minute ventilation with measured minute ventilation in a rate responsive pacemaker. Pacing Clin Electrophysiol. 2001;24:989 -993. (Pubitemid 32681211)
44. Page E, Cazeau S, Ritter P, Galley D, Casset C. Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace. 2007;9:687- 693. (Pubitemid 47263805)
45. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010;55:1803-1810.
46. Kadhiresan VA, Pastore J, Auricchio A, Sack S, Doelger A, Girouard S, Spinelli JC. A novel method-the activity log index-for monitoring physical activity of patients with heart failure. Am J Cardiol. 2002;89: 1435-1437. (Pubitemid 34607791)
47. Ohlsson A, Kubo SH, Steinhaus D, Connelly DT, Adler S, Bitkover C, Nordlander R, Ryden L, Bennett T. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J. 2001;22: 942-954. (Pubitemid 32625217)
48. Kjellstrom B, Linde C, Bennett T, Ohlsson A, Ryden L. Six years follow-up of an implanted SvO(2) sensor in the right ventricle. Eur J Heart Fail. 2004;6:627- 634. (Pubitemid 39070518)
49. Rickards AF, Bombardini T, Corbucci G, Plicchi G. An implantable intracardiac accelerometer for monitoring myocardial contractility: the Multicenter PEA Study Group. Pacing Clin Electrophysiol. 1996;19: 2066-2071.
50. Dupuis JM, Kobeissi A, Vitali L, Gaggini G, Merheb M, Rouleau F, Leftheriotis G, Ritter P, Victor J. Programming optimal atrioventricular delay in dual chamber pacing using peak endocardial acceleration: comparison with a standard echocardiographic procedure. Pacing Clin.
51. Delnoy PP, Marcelli E, Oudeluttikhuis H, Nicastia D, Renesto F, Cercenelli L, Plicchi G. Validation of a peak endocardial acceleration-based algorithm to optimize cardiac resynchronization: early clinical results. Europace. 2008;10:801- 808. (Pubitemid 351882066)
52. Vanderheyden M, Houben R, Verstreken S, Stahlberg M, Reiters P, Kessels R, Braunschweig F. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure. Circ Heart Fail. 2010;3:370 -377.
53. O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7:13-20.
54. von Haehling S, Schefold JC, Lainscak M, Doehner W, Anker SD. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail Clin. 2009;5:549 -560.
55. Reichlin T, Socrates T, Egli P, Potocki M, Breidthardt T, Arenja N, Meissner J, Noveanu M, Reiter M, Twerenbold R, Schaub N, Buser A, Mueller C. Use of myeloperoxidase for risk stratification in acute heart failure. Clin Chem. 2010;56:944 -951.
56. Kanoupakis EM, Manios EG, Kallergis EM, Mavrakis HE, Goudis CA, Saloustros IG, Milathianaki ME, Chlouverakis GI, Vardas PE. Serum markers of collagen turnover predict future shocks in implantable cardioverter- defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol. 2010;55: 2753-2759.
57. Isserlin R, Merico D, Alikhani-Koupaei R, Gramolini A, Bader GD, Emili A. Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps. Proteomics. 2010;10:1316 -1327.
58. Romero E, Warrington RO, Neuman MR. Energy scavenging sources for biomedical sensors. Physiol Meas. 2009;30:R35-R62.
59. Nuxoll EE, Siegel RA. BioMEMS devices for drug delivery. IEEE Eng Med Biol Mag. 2009;28:31-39.
60. Salazar C, Abraham WT. Biventricular and novel pacing mechanisms in heart failure. Curr Heart Fail Rep. 2009;6:14 -18.